Variant report
Variant | esv1828578 |
---|---|
Chromosome Location | chr3:68595321-68641509 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs578095698 | chr3:68599051-68599052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145986418 | chr3:68599089-68599090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530162418 | chr3:68599090-68599091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148754096 | chr3:68599119-68599120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367809170 | chr3:68599124-68599125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543217506 | chr3:68599177-68599178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559153326 | chr3:68599178-68599179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528150565 | chr3:68599213-68599214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs180678907 | chr3:68599214-68599215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73101396 | chr3:68599215-68599216 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs530467702 | chr3:68599220-68599221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371202162 | chr3:68599230-68599231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73101398 | chr3:68599259-68599260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567559119 | chr3:68599320-68599321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185987534 | chr3:68599363-68599364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546793681 | chr3:68599391-68599392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111525922 | chr3:68599432-68599433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566701593 | chr3:68599441-68599442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1533154 | chr3:68599501-68599502 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs558325719 | chr3:68599527-68599528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs578068076 | chr3:68599532-68599533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368692580 | chr3:68599554-68599555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552126997 | chr3:68599556-68599557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557331942 | chr3:68599567-68599568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs77355470 | chr3:68599568-68599569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192251237 | chr3:68599576-68599577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184084311 | chr3:68599651-68599652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185771569 | chr3:68599659-68599660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550659624 | chr3:68599672-68599673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370340726 | chr3:68599730-68599731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547803892 | chr3:68599751-68599752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544698575 | chr3:68599772-68599773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs76634053 | chr3:68599791-68599792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530383869 | chr3:68599826-68599827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550564708 | chr3:68599832-68599833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560996758 | chr3:68599842-68599843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529978639 | chr3:68599869-68599870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540899086 | chr3:68599908-68599909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570722940 | chr3:68599928-68599929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs4550825 | chr3:68599933-68599934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13319937 | chr3:68599941-68599942 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs73103304 | chr3:68600022-68600023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551853397 | chr3:68600043-68600044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142338717 | chr3:68600123-68600124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190622278 | chr3:68600126-68600127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182931946 | chr3:68600127-68600128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567584051 | chr3:68600153-68600154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536939903 | chr3:68600156-68600157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556392074 | chr3:68600158-68600159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186895492 | chr3:68600179-68600180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Breast cancer | 17142309 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:68599000-68599600 | Enhancers | H9 Cell Line | embryonic stem cell |
2 | chr3:68599400-68599600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr3:68599600-68601000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr3:68602200-68602800 | Enhancers | Colon Smooth Muscle | Colon |
5 | chr3:68605000-68605800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr3:68610000-68612000 | Enhancers | Fetal Lung | lung |
7 | chr3:68620000-68620600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr3:68620600-68620800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr3:68620800-68622400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr3:68622400-68622600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr3:68624400-68625000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr3:68624600-68625200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr3:68628200-68628400 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |